Previous close | 4.4900 |
Open | 4.5550 |
Bid | 4.2600 x 200 |
Ask | 4.3000 x 200 |
Day's range | 4.2700 - 4.6000 |
52-week range | 1.0800 - 5.0000 |
Volume | |
Avg. volume | 1,169,121 |
Market cap | 223.242M |
Beta (5Y monthly) | 1.70 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.6000 |
Earnings date | 31 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 8.50 |
Shareholders of G1 Therapeutics, Inc. ( NASDAQ:GTHX ) will be pleased this week, given that the stock price is up 13...
G1 Therapeutics ( NASDAQ:GTHX ) First Quarter 2024 Results Key Financial Results Revenue: US$14.5m (up 12% from 1Q...
G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript May 1, 2024 G1 Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.2 EPS, expectations were $-0.19. GTHX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank […]